Viruses · 2022 · 24 citations · 43 references
PharmacyImmunologyInfectious DiseasesClinical ImmunologyEmerging Infectious DiseasesImmunology Of Infectious DiseasesAntibody CharacterizationAntibody FunctionAntibody ScreeningAntibody-antigen RecognitionAntibodiesCross-reactive AntigensCross-reactive ImmunityNeutralizing Antibody PrevalencePre-existing Antibody ResponsesPre-existing ImmunitySars-cov-2 InfectionSevere Acute Respiratory Syndrome
For more than two years after the emergence of COVID-19 (Coronavirus Disease-2019), significant regional differences in morbidity persist. These differences clearly show lower incidence rates in several regions of the African and Asian continents. The work reported here aimed to test the hypothesis of a pre-pandemic natural immunity acquired by some human populations in central and western Africa, which would, therefore, pose the hypothesis of an original antigenic sin with a virus antigenically close to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). To identify such pre-existing immunity, sera samples collected before the emergence of COVID-19 were tested to detect the presence of IgG reacting antibodies against SARS-CoV-2 proteins of major significance. Sera samples from French blood donors collected before the pandemic served as a control. The results showed a statistically significant difference of antibodies prevalence between the collected samples in Africa and the control samples collected in France. Given the novelty of our results, our next step consists in highlighting neutralizing antibodies to evaluate their potential for pre-pandemic protective acquired immunity against SARS-CoV-2. In conclusion, our results suggest that, in the investigated African sub-regions, the tested populations could have been potentially and partially pre-exposed, before the COVID-19 pandemic, to the antigens of a yet non-identified Coronaviruses.
43
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang et al. · Nature · 2020 · 23.3K citations · Full text
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 9.1K citations · Full text
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan, Jiwan Ge, Jinfang Yu et al. · Nature · 2020 · 6.7K citations · Full text
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Wendong Li, Meng Yu, Wuze Ren et al. · Science · 2005 · 2.7K citations · Full text
Veterinary Medicine, Infectious Diseases, Molecular Virology +14
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran et al. · Nature · 2020 · 2.2K citations · Full text